Some experts think greater price transparency could reduce healthcare costs by fostering more competition, while others are concerned about the potential effects on hospital-payer negotiations, as well as the practicality of enforcing these requirements.
This week, UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare Advantage billing practices, and the second was a Congressman's investigation into a decline in care quality at Optum-owned clinics in New York.
Recent CounselLink upgrades integrate the full in-house workflow with the broader suite of LexisNexis products.
The contract negotiation process between providers and payers is now more complex than ever, according to Baptist Health CEO Michael Mayo.
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.
Healthcare AI is developing at a rapid rate, and the industry’s attitude on how to best regulate and deploy this technology is evolving every day.
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years.
Contracts are now integrated into an end-to-end system, and efficiencies abound.
The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders hope he addresses issues relating to health coverage, drug costs, and more.
Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a bill last week that would require ‘able-bodied adults’ without dependents to work or volunteer for at least 20 hours per week to receive Medicaid benefits.
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see.
From training to technology, uncover the essential steps to futureproof your law firm in a competitive market.
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA, and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley.
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question?
ICHRAs are gaining a lot of interest in healthcare. Some say they are beneficial because they give employees more choice in their health insurance, while others are more skeptical.
Recognizing its vulnerability to cybercrime, the healthcare industry continues to prioritize cybersecurity. Here are some areas where organizations should be focusing their efforts.
